FDA Clears International Stem Cell Corporation Line of Stem Cells for Clinical Use – Diabetes Insider
The Express Tribune (blog) |
FDA Clears International Stem Cell Corporation Line of Stem Cells for Clinical Use
Diabetes Insider The company is geared towards the therapeutic uses of human parthenogenetic stem cells and is working to develop and commercialize cell based analysis and cosmetic applications. The ISCO core technology, parthenogenesis, is responsible for creating … Stem cell research and ethical dilemmas: How far have we come? Stem cells directed towards embryo development |
